Primary central nervous system lymphoma in a patient treated with natalizumab.


Autoria(s): Phan-Ba R.; Bisig B.; Deprez M.; De Prijck B.; Delrue G.; Herens C.; Moonen G.; Belachew S.; de Leval L.
Data(s)

2011

Identificador

https://serval.unil.ch/?id=serval:BIB_0211F8C0874F

isbn:1531-8249 (Electronic)

pmid:21328606

doi:10.1002/ana.22296

isiid:000292003100019

Idioma(s)

en

Fonte

Annals of Neurology, vol. 69, no. 6, pp. 1060-1; author reply 1061-2

Palavras-Chave #Adult; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Brain/pathology; Central Nervous System Neoplasms/drug therapy; Humans; Immunologic Factors/therapeutic use; Lymphoma/drug therapy; Magnetic Resonance Imaging; Male
Tipo

info:eu-repo/semantics/article

article